Clinical trials
Not yet recruiting Phase 1 Glioblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Olivia Newton-John Cancer Research Institute | 2 |
| AstraZeneca | 1 |
| Beijing Tricision Biotherapeutics Inc | 1 |
| Catalina Lee Chang | 1 |
| City of Hope Medical Center | 1 |
| Crimson Biopharm Inc. | 1 |
| Jennifer Leddon | 1 |
| Lumina Pharmaceuticals Inc | 1 |
| Medical College of Wisconsin | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 17 |
| Glioma | 5 |
| Brain Neoplasms | 2 |
| Diffuse Intrinsic Pontine Glioma | 2 |
| Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Gliosarcoma | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.